Abstract
Ferritin is a widely used marker of iron status. A relationship between iron stores, obesity and metabolic syndrome (METs) has been proposed.
Objective: To compare serum ferritin between obese women with and without METs, and to evaluate the main factors accounting for ferritin levels.
Design: Prospective study.
Subjects: A total of 239 consecutive postmenopausal women with body mass index (BMI) ⩾30 kg/m2 were included. Exclusion criteria were conditions that could influence body iron stores. In addition to ferritin, serum iron, transferrin, transferrin saturation index and the soluble transferrin receptor were measured. METs was defined according to the International Diabetes Federation guidelines. Multiple regression analyses were performed taking into account ferritin as the dependent variable.
Results: Serum ferritin levels were significantly higher in obese women with METs (n=169) in comparison with obese women without METs (n=70): 81.00 (17–648) vs 48.50 (11–149) ng ml−1, P<0.001. No differences in the other markers of iron status were observed. Diabetic patients (n=82) had higher ferritin levels than non-diabetic patients (P<0.001). Non-diabetic patients with METs (n=95) also showed higher ferritin levels than non-diabetic patients without METs (P=0.001). Among the components of METs only diabetes was independently associated with serum ferritin levels in both the whole group (P=0.02) and in patients with METs (P=0.005).
Conclusion: Metabolic syndrome and in particular type 2 diabetes is the main contributor to the high ferritin levels reported in obesity. Our findings suggest that ferritin should not be used as a reliable index of iron overload in obese patients with diabetes.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Oshang A, Bugge KH, Bjones CH, Borch-Iohnsen B, Neslein IL . Associations between serum ferritin and cardiovascular risk factors in healthy young men. A cross sectional study. Eur J Clin Nutr 1995; 49: 430–438.
Jehn M, Clark JM, Guallar E . Serum ferritin and risk of the metabolic syndrome in US adults. Diabetes Care 2004; 27: 2422–2428.
Guillum RF . Association of serum ferritin and indices of body fat distribution and obesity in Mexican American men: the Third National Health and Nutrition Examination Survey. Int J Obes Relat Metab Disord 2001; 25: 639–645.
Illouz F, Roulier V, Rod A, Gallois Y, Pellé CP, Aubé C et al. Distribution of adipose tissue: quantification and relationship with hepatic steatosis and vascular profiles of type 2 diabetic patients with metabolic syndrome. Diabetes Metab 2008; 34: 68–74.
Gabay C, Kushner I . Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340: 448–454.
Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB . Elevated c-reactive protein levels in overweight and obese adults. JAMA 1999; 282: 2131–2135.
Fernández-Real JM, Ricart W . Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev 2003; 24: 278–301.
Hernández C, Lecube A, Carrera A, Simó R . Soluble transferrin receptors and ferritin in Type 2 diabetic patients. Diabet Med 2005; 22: 97–101.
International Diabetes Federation: the IDF consensus worldwide definition of the metabolic syndrome [article online], 2005. Available from www.idf.org/webdata/docs/IDFmetasyndromedefinition.pdf.
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2005; 28: S37–S42.
McLaughlin T, Abbasi F, Cheal K, Chu J, Lamendola C, Reaven G . Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med 2003; 139: 802–809.
Zacharski L, Ornstein D, Woloshin S, Schwartz L . Association of age, sex, and race with body iron stores in adults: analysis of NHANES III data. Am Heart J 2000; 140: 98–104.
Haap M, Fritsche A, Mensing HJ, Haring HU, Stumvoll M . Association of high serum ferritin concentration with glucose intolerance and insulin resistance in healthy people. Ann Intern Med 2003; 139: 869–871.
Mendler MH, Turlin B, Moirand R, Jouanolle AM, Sapey T, Guyader D et al. Insulin resistance-associated hepatic iron overload. Gastroenterology 1999; 117: 1155–1163.
Salonen JT, Tuomainen TP, Nyyssönen K, Lakka HM, Punnonen K . Relation between iron stores and non-insulin dependent diabetes in men: case–control study. BMJ 1998; 317: 727.
Jiang R, Manson JE, Meigs JB, Ma J, Rifai N, Hu FB . Body iron stores in relation to risk of type 2 diabetes in apparently healthy women. JAMA 2004; 291: 711–717.
Ford ES, Cogswell ME . Diabetes and serum ferritin concentrations among US adults. Diabetes Care 1999; 22: 1978–1983.
Lecube A, Hernández C, Genescà J, Esteban JI, Jardí R, García L et al. Diabetes is the main factor accounting for the high ferritin levels detected in chronic hepatitis C virus infection. Diabetes Care 2004; 27: 2669–2675.
Dinneen SF, Silverberg JD, Batts KP, O’Brien PC, Ballard DJ, Rizza RA . Liver iron stores in patients with non-insulin-dependent diabetes mellitus. Mayo Clin Proc 1994; 69: 13–15.
Bugianesi E, Manzini P, D’Antico S, Van E, Longo F, Leone N et al. Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in non-alcoholic fatty liver. Hepatology 2004; 39: 179–187.
Mast AE, Blinder MA, Gronowski AM, Chumley C, Scott MG . Clinical utility of the soluble transferrin receptor and comparison with serum ferritin in several populations. Clin Chem 1998; 44: 45–51.
Hotamisligil GS . The role of TNF alpha and TNF receptors in obesity and insulin resistance. J Intern Med 1999; 245: 621–625.
Pickup JC, Chusney GD, Thomas SM, Burt D . Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetes. Life Sci 2000; 67: 291–300.
Nead KG, Halterman JS, Kaczorowski JM, Auinger P, Weitzman M . Overweight children and adolescents: a risk group for iron deficiency. Pediatrics 2004; 114: 104–108.
Yanoff LB, Menzie CM, Denkinger B, Sebring NG, McHugh T, Remaley AT et al. Inflammation and iron deficiency in the hypoferremia of obesity. Int J Obes (Lond) 2007; 31: 1412–1419.
Lecube A, Carrera A, Losada E, Hernández C, Simó R, Mesa J . Iron deficiency in obese postmenopausal women. Obesity 2006; 14: 1724–1730.
Acknowledgements
This study was supported by grants from Novo Nordisk Pharma (01/0066), and CIBERdem from the Instituto de Salud Carlos III.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lecube, A., Hernández, C., Pelegrí, D. et al. Factors accounting for high ferritin levels in obesity. Int J Obes 32, 1665–1669 (2008). https://doi.org/10.1038/ijo.2008.154
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ijo.2008.154
Keywords
This article is cited by
-
The association between triglyceride-glucose index and hyperferritinemia in patients with type 2 diabetes mellitus
Hormones (2023)
-
Factors associated with serum ferritin levels and iron excess: results from the EPIC-EurGast study
European Journal of Nutrition (2022)
-
Impact of visceral fat on the prognosis of coronavirus disease 2019: an observational cohort study
BMC Infectious Diseases (2021)
-
Controlling Nutritional Status (CONUT) Score and Micronutrient Deficiency in Bariatric Patients: Midterm Outcomes of Roux-en-Y Gastric Bypass Versus One Anastomosis Gastric Bypass/Mini Gastric Bypass
Obesity Surgery (2021)
-
Nonalcoholic Steatohepatitis Modifies Serum Iron-Related Variables in Patients with Morbid Obesity
Biological Trace Element Research (2021)